CDEK
← All drugs Report issue

uttr1147a

Recombinant proteinexperimental

Clinical trial activity

6 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2016 (NCT02749630)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • uttr1147a

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04539470Phase 1Nov 19, 2020Genentech
NCT04386616Phase 2May 22, 2020Genentech
NCT03558152Phase 2Nov 30, 2018Genentech, Roche
NCT03650413Phase 2Oct 15, 2018Genentech, Roche
NCT02833389Phase 1May 1, 2016Genentech, Roche
NCT02749630Phase 1Apr 1, 2016Genentech, Roche
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GenentechFor profit6622016
RocheFor profit4022016
2 organizations
Page 1 / 1